In this Issue:
Diagnostic value of 68Ga-PSMA-ligand PET/CT
ERSPC at 13 years of follow-up
Bone-targeted strontium-89 therapy in advanced castrate-sensitive prostate cancer
Suicidal ideation in prostate cancer survivors
PCA3 plus PSA for detection of prostate cancer
aRT for patients with node-positive prostate cancer
ALSYMPCA trial: previous docetaxel treatment subgroup analysis
Impact of enzalutamide on quality of life
ADT exposure and bone complications
Please login below to download this issue (PDF)